drugset
drugset / Trial / NCT00753246

Nimotuzumab in Adults With Glioblastoma Multiforma

NCT00753246 ↗

Phase 3 Completed 150 enrolled Oncoscience AG Dep. of Neurosurgery and Policlinic, University Hospital, Dresden, Germany · collabDr. von Haunersches Children's Medical Hospital, University of Munich, Germany · collabHeinrich-Heine University, Duesseldorf · collabJohann Wolfgang Goethe University Hospital · collabNeurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany · collabUniversity of Bonn · collabUniversity of Giessen · collabUniversity of Kiel · collabUniversität Tübingen · collabUniversitätsklinikum Hamburg-Eppendorf · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Determination of efficiency of nimotuzumab in adults with glioblastoma multiforma

Timeline

Start
2007-08
Primary completion
—
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nimotuzumab Monoclonal antibody — —

Indications

adult glioblastoma